TrialRheumatology (Oxford, England)2023

A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).

Deborah J Griffiths-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.